Displaying 1-8 of 8 result(s).
| Board Name | Posts By kerplunk | Post Created |
|---|---|---|
| IPIX Innovation Pharmaceuticals Inc | minions/bashers/idiots had NOTHING  (3) | 05/14/2019 7:00:50 AM |
| IPIX Innovation Pharmaceuticals Inc | Talk about a posting in doubt...... | 05/12/2019 9:56:24 AM |
| IPIX Innovation Pharmaceuticals Inc | Frrol I think Leo let something sli (2) | 05/11/2019 10:12:21 AM |
| IPIX Innovation Pharmaceuticals Inc | Leo was hoping that this 8-K would | 05/10/2019 10:01:56 AM |
| IPIX Innovation Pharmaceuticals Inc | Drano maybe you should explain your | 05/10/2019 9:59:38 AM |
| IPIX Innovation Pharmaceuticals Inc | from .42 to .21.. EVERYBODY MUST BE  (1) | 05/10/2019 9:50:35 AM |
| IPIX Innovation Pharmaceuticals Inc | Obviously NO leaked information as (1) | 05/10/2019 9:45:21 AM |
| IPIX Innovation Pharmaceuticals Inc | DOWN 25% ALREADY. This is pathetic! | 05/10/2019 9:39:08 AM |
Recent Articles
- Tesla's Upcoming Earnings: Focus on Robotaxis and AI Integration
- Trump's Warning: Supreme Court Ruling May Harm U.S. Economy
- BC.GAME Esports Welcomes CS Major Champion electronic to Squad
- Elon Musk Defends Tesla's CEO Compensation Amid Criticism
- Chery Group Strengthens Commitment to Global Education Initiatives
- Revolutionizing Workplace Comfort with Elevated Seating Innovation
- Established Tech Giants Poised to Lead in AI Development
- ENGWE's Innovative Journey: Connecting E-Bike Riders Worldwide
- Investigation Ongoing After Daring Jewelry Heist at Louvre
- Unveiling Sustainable Solutions: Insights from Global Leaders
- SKYWORTH Launches Revolutionary Matte Screen Ultra TV Series
- Exciting Advances in Lung Cancer Treatment with Sacituzumab Tirumotecan
- MoonLake Immunotherapeutics: A Call to Action for Investors
- Investors Urged to Act Quickly in PubMatic Class Action Suit
- Tragic Cargo Plane Incident at Hong Kong Airport Sparks Concerns
- Christine Lagarde's Insight: Upcoming Tariff Effects on U.S. Consumers
- Insights on the Upcoming Financial Street Forum in Beijing
- Antengene Advances ATG-022: Promising Clinical Outcomes Revealed
- Investigation Announcement for Baxter International Investors
- Cytokinetics Investors: Secure Representation Before Deadline
- Jasper Therapeutics Investors: Important Class Action Deadline Ahead
- Mesoblast Limited Reports Significant Revenue Growth After Ryoncil Launch
- CStone Pharmaceuticals Shares Promising Phase I Results for CS2009
- Ascletis Completes Enrollment in Phase IIa Study of ASC30.
- Innovations in Pancreatic Cancer Treatment with Satri-cel
- Cambodia's Techo International Airport: A Gateway to Growth
- Record Growth in Q2 Revenues Enhances Mesoblast's Market Position
- Faraday Future's Vision: Accelerating Towards FX Super One Launch
- IZERVAY™ Delivers Long-Term Benefits for Geographic Atrophy Patients
- Clover Biopharmaceuticals Names Nicholas Jackson as President
- Dr. Luke Wainscoat Brings Expertise to The Brattle Group
- Kering and L'Oréal Unite to Transform Luxury Beauty Sector
- Kering and L’Oréal: A New Era in Luxury Beauty and Wellness
- Kering Partners with L'Oréal to Transform Luxury Beauty Sector
- Alice Walton and Elon Musk: Giants of Wealth in 2025
- Clarins and V Magazine Host a Glamorous Golden Hour Event
- Sobi Adjusts Revenue Forecast for 2025 Amid Strong Q3 Growth
- Sobi Updates Full-Year Outlook and Q3 2025 Financial Report
- Exploring NB HASH and the Transformation of Wealth Today
- Kevin Hart's Journey From Investment Missteps to Business Success
- BlackRock's Strategic Shift: The Future of Investment in RWA
- Major Contract Termination Announced by Vantage Drilling
- Deadline Approaches for Dow Inc. Investors Amid Legal Action
- Important Update for Cepton, Inc. Investors on Class Action
- Target and Walmart Thrive Amid Collectible Card Sales Surge
- Snap Investors Urged to Consider Leading Legal Action
- Unlocking Wealth Potential: The RWA Revolution Explained
- Embracing Real-World Assets with NB HASH for Sustainable Growth
- Nutex Health Investors Can Join Class Action Against Company
- Potential Legal Action for Baxter International Investors